Quick Takeaways
- Gregory L. Weaver has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $119,977.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Gregory L. Weaver and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ALT | Altimmune, Inc. | Chief Financial Officer | $119,941 | +$49,199 | +70% | 01 Apr 2026 |
| ATOS | ATOSSA THERAPEUTICS, INC. | Former EVP, CFO, & Director, Director | $36 | 15 Nov 2023 | ||
| ATAI | ATAI Life Sciences N.V. | Chief Financial Officer | 02 Mar 2022 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|